Marc Earl

482 total citations
24 papers, 288 citations indexed

About

Marc Earl is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Marc Earl has authored 24 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Hematology. Recurrent topics in Marc Earl's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Marc Earl is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Marc Earl collaborates with scholars based in United States and India. Marc Earl's co-authors include Connie Cheng, Anjali S. Advani, Jun‐Yen Yeh, Matt Kalaycio, Mikkael A. Sekeres, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Michael Rytting, Archie Bleyer and Dan Douer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Marc Earl

24 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Earl United States 11 137 92 73 62 34 24 288
Rachel Clack United Kingdom 6 90 0.7× 101 1.1× 74 1.0× 51 0.8× 23 0.7× 13 242
Amber B. Clemmons United States 12 91 0.7× 59 0.6× 35 0.5× 71 1.1× 39 1.1× 38 326
Rasha El‐Ashry Egypt 11 65 0.5× 48 0.5× 44 0.6× 40 0.6× 60 1.8× 24 297
Jingbo Yu United States 11 333 2.4× 69 0.8× 50 0.7× 14 0.2× 52 1.5× 18 533
Saad Al‐Ismail United Kingdom 13 100 0.7× 55 0.6× 81 1.1× 99 1.6× 32 0.9× 29 355
Samit Patel United States 11 67 0.5× 43 0.5× 38 0.5× 63 1.0× 47 1.4× 25 294
Tarek Owaidah Saudi Arabia 10 31 0.2× 76 0.8× 40 0.5× 203 3.3× 32 0.9× 41 384
Laura Winter United States 10 171 1.2× 171 1.9× 95 1.3× 307 5.0× 127 3.7× 20 538
Bhuvan Pathak United States 9 186 1.4× 134 1.5× 61 0.8× 25 0.4× 11 0.3× 15 319
Suar Çakı Kılıç Türkiye 10 29 0.2× 50 0.5× 55 0.8× 134 2.2× 31 0.9× 31 268

Countries citing papers authored by Marc Earl

Since Specialization
Citations

This map shows the geographic impact of Marc Earl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Earl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Earl more than expected).

Fields of papers citing papers by Marc Earl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Earl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Earl. The network helps show where Marc Earl may publish in the future.

Co-authorship network of co-authors of Marc Earl

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Earl. A scholar is included among the top collaborators of Marc Earl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Earl. Marc Earl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Earl, Marc, et al.. (2020). Comparison of IV oncology infusions compounded via robotics and gravimetrics-assisted workflow processes. American Journal of Health-System Pharmacy. 78(2). 122–134. 9 indexed citations
2.
Earl, Marc, et al.. (2020). Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center. Journal of Oncology Pharmacy Practice. 27(6). 1454–1460. 4 indexed citations
3.
Roman, Danielle, et al.. (2018). ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy. American Journal of Health-System Pharmacy. 75(17). 1304–1311. 1 indexed citations
4.
Rose, Robert M., et al.. (2018). Development of an operational productivity tool within a cancer treatment center pharmacy. American Journal of Health-System Pharmacy. 75(21). 1736–1741. 8 indexed citations
5.
6.
Cheng, Connie, et al.. (2015). Use of atropine-diphenoxylate compared with hyoscyamine to decrease rates of irinotecan-related cholinergic syndrome. The Journal of Community and Supportive Oncology. 13(1). 3–7. 13 indexed citations
7.
Pi, Judy, et al.. (2015). A review in the treatment of oncologic emergencies. Journal of Oncology Pharmacy Practice. 22(4). 625–638. 14 indexed citations
8.
Keng, Michael, Paul Elson, Jennifer Sekeres, et al.. (2014). Defining quality and value in a prospective study of an emergency department (ED) febrile neutropenia pathway (FNP).. Journal of Clinical Oncology. 32(15_suppl). 6632–6632. 1 indexed citations
9.
Cheng, Connie, et al.. (2014). Rates of febrile neutropenia with pegfilgrastim on same day versus next day of CHOP with or without rituximab. Anti-Cancer Drugs. 25(8). 964–969. 28 indexed citations
10.
11.
Earl, Marc, Jun‐Yen Yeh, Anjali S. Advani, et al.. (2013). Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight. American Journal of Hematology. 88(10). 906–909. 34 indexed citations
12.
Sun, Di, Paul Elson, Michaela Liedtke, et al.. (2012). Absolute lymphocyte count at day 28 independently predicts event‐free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia. American Journal of Hematology. 87(10). 957–960. 19 indexed citations
13.
Earl, Marc, Jun‐Yen Yeh, Anjali S. Advani, et al.. (2011). Fluoroquinolone Prophylaxis in Acute Myeloid Leukemia (AML) Patients Undergoing Post-Remission Chemotherapy Reduces Hospital Admission Rates. Blood. 118(21). 2570–2570. 2 indexed citations
14.
Brady, Anna K., Alex Z. Fu, Marc Earl, et al.. (2010). Race and intensity of post-remission therapy in acute myeloid leukemia. Leukemia Research. 35(3). 346–350. 10 indexed citations
15.
Earl, Marc, Alex Z. Fu, Matt Kalaycio, et al.. (2010). Outcomes In Acute Myeloid Leukemia (AML) Patients Diagnosed with Myeloid Sarcoma with and without Bone Marrow Involvement. Blood. 116(21). 2165–2165. 2 indexed citations
16.
17.
Brady, Anna K., Alex Z. Fu, Marc Earl, et al.. (2009). Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).. Blood. 114(22). 1012–1012. 1 indexed citations
18.
Earl, Marc. (2009). Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.. PubMed. 7(9). 600–6. 44 indexed citations
19.
Rytting, Michael, et al.. (2008). Toxicities in Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Regimens Using Pegasparaginase.. Blood. 112(11). 1924–1924. 12 indexed citations
20.
Advani, Anjali S., Marc Earl, Dan Douer, Michael Rytting, & Archie Bleyer. (2007). Toxicities of Intravenous (IV) Pegasparaginase (ONCASPAR®) in Adults with Acute Lymphoblastic Leukemia (ALL).. Blood. 110(11). 2811–2811. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Clack Breakdown of academic impact, for papers by Amber B. Clemmons Breakdown of academic impact, for papers by Rasha El‐Ashry Breakdown of academic impact, for papers by Jingbo Yu Breakdown of academic impact, for papers by Saad Al‐Ismail Breakdown of academic impact, for papers by Samit Patel Breakdown of academic impact, for papers by Tarek Owaidah Breakdown of academic impact, for papers by Laura Winter Breakdown of academic impact, for papers by Bhuvan Pathak Breakdown of academic impact, for papers by Suar Çakı Kılıç
Rankless by CCL
2026